Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...

On January 5, Ashley began a demanding 14-day, 106-mile trek called “The Keys for a Cure” to raise funds and awareness for PF. Starting from mile marker 106 in Key Largo, he plans to walk an average ...

The updated guidelines from the American Diabetes Association emphasize the use of antibody-based screening for type 1 ...

Gastric cancer, commonly known as stomach cancer, is the fifth most common cancer globally and the fifth leading cause of cancer-related deaths.

Kamilia Smith, MD, FACOG, NCMP, discusses how shared decision-making approaches combined with emerging neurokinin-targeted therapies offer promising solutions to improve treatment adherence and ...

Few studies in this analysis assessed the accuracy of AI in detecting melanoma in diverse skin tones. AI can detect skin cancer with 95% accuracy, but the technology won’t replace dermatologists until ...

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...

Modern research shows women’s health issues go beyond reproductive health and highlight women’s elevated risk for autoimmune and cardiovascular disease – among other conditions.

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...

Regenerative medicine focuses on repairing damaged skin and bringing back melanocytes, the cells that give skin its color.

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.